Desmopressin
- Generic Name
- Desmopressin
- Brand Names
- Ddavp, Nocdurna, Octostim
- Drug Type
- Small Molecule
- Chemical Formula
- C46H64N14O12S2
- CAS Number
- 16679-58-6
- Unique Ingredient Identifier
- ENR1LLB0FP
- Background
Desmopressin (dDAVP), a synthetic analogue of 8-arginine vasopressin (ADH), is an antidiuretic peptide drug modified by deamination of 1-cysteine and substitution of 8-L-arginine by 8-D-arginine. ADH is an endogenous pituitary hormone that has a crucial role in the control of the water content in the body. Upon release from the stimulation of increased plasm...
- Indication
1.治疗中枢性尿崩症，可减少尿量、提高尿渗透压、降低血浆渗透压；
2.用于尿崩症的诊断和鉴别诊断；
3.用于治疗夜间遗尿症（六岁或以上的患者）；
4.部分类型（甲型血友病和Ⅰ型血管性假血友病）的血友病及其他出血性疾病。
- Associated Conditions
- Bleeding, Hypothalamic Injury-induced Obesity (HIO), Nocturia, Nocturnal Polyuria, Polydipsia, Polyuria, Primary Nocturnal Enuresis
- Associated Therapies
- -
Exploring drug shortages in european markets: the causes, analysis, and response
Pharmaceutical industry in Europe faces drug shortages due to high operating costs and government cost-containment policies. Norway reports the most shortages, with generics and on-patent medicines affected. Pricing and reimbursement policy changes are being considered to address these issues.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath